These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 23862238)

  • 1. [Molecular mechanisms of leupaxin involved in prostate carcinoma metastasis].
    Zhu GH; Dai HP; Shen Q
    Zhonghua Nan Ke Xue; 2013 Jun; 19(6):555-8. PubMed ID: 23862238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Leupaxin stimulates adhesion and migration of prostate cancer cells through modulation of the phosphorylation status of the actin-binding protein caldesmon.
    Dierks S; von Hardenberg S; Schmidt T; Bremmer F; Burfeind P; Kaulfuß S
    Oncotarget; 2015 May; 6(15):13591-606. PubMed ID: 26079947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A protein coupling and molecular simulation analysis of the clinical mutants of androgen receptor revealed a higher binding for Leupaxin, to increase the prostate cancer invasion and motility.
    Khan A; Li W; Ambreen A; Wei DQ; Wang Y; Mao Y
    Comput Biol Med; 2022 Jul; 146():105537. PubMed ID: 35504219
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction of Pyk2 and PTP-PEST with leupaxin in prostate cancer cells.
    Sahu SN; Nunez S; Bai G; Gupta A
    Am J Physiol Cell Physiol; 2007 Jun; 292(6):C2288-96. PubMed ID: 17329398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leupaxin acts as a mediator in prostate carcinoma progression through deregulation of p120catenin expression.
    Kaulfuss S; von Hardenberg S; Schweyer S; Herr AM; Laccone F; Wolf S; Burfeind P
    Oncogene; 2009 Nov; 28(45):3971-82. PubMed ID: 19701244
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Leupaxin Promotes Bladder Cancer Proliferation, Metastasis, and Angiogenesis Through the PI3K/AKT Pathway.
    Hou T; Zhou L; Wang L; Kazobinka G; Chen Y; Zhang X; Chen Z
    Cell Physiol Biochem; 2018; 47(6):2250-2260. PubMed ID: 29975926
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leupaxin, a novel coactivator of the androgen receptor, is expressed in prostate cancer and plays a role in adhesion and invasion of prostate carcinoma cells.
    Kaulfuss S; Grzmil M; Hemmerlein B; Thelen P; Schweyer S; Neesen J; Bubendorf L; Glass AG; Jarry H; Auber B; Burfeind P
    Mol Endocrinol; 2008 Jul; 22(7):1606-21. PubMed ID: 18451096
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXC8 inhibits androgen receptor signaling in human prostate cancer cells by inhibiting SRC-3 recruitment to direct androgen target genes.
    Axlund SD; Lambert JR; Nordeen SK
    Mol Cancer Res; 2010 Dec; 8(12):1643-55. PubMed ID: 21047772
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leupaxin is similar to paxillin in focal adhesion targeting and tyrosine phosphorylation but has distinct roles in cell adhesion and spreading.
    Chen PW; Kroog GS
    Cell Adh Migr; 2010; 4(4):527-40. PubMed ID: 20543562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Control of androgen receptor signaling in prostate cancer by the cochaperone small glutamine rich tetratricopeptide repeat containing protein alpha.
    Buchanan G; Ricciardelli C; Harris JM; Prescott J; Yu ZC; Jia L; Butler LM; Marshall VR; Scher HI; Gerald WL; Coetzee GA; Tilley WD
    Cancer Res; 2007 Oct; 67(20):10087-96. PubMed ID: 17942943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Leupaxin is expressed in mammary carcinoma and acts as a transcriptional activator of the estrogen receptor α.
    Kaulfuss S; Herr AM; Büchner A; Hemmerlein B; Günthert AR; Burfeind P
    Int J Oncol; 2015 Jul; 47(1):106-14. PubMed ID: 25955236
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth hormone (GH) receptors in prostate cancer: gene expression in human tissues and cell lines and characterization, GH signaling and androgen receptor regulation in LNCaP cells.
    Weiss-Messer E; Merom O; Adi A; Karry R; Bidosee M; Ber R; Kaploun A; Stein A; Barkey RJ
    Mol Cell Endocrinol; 2004 May; 220(1-2):109-23. PubMed ID: 15196705
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.
    Unni E; Sun S; Nan B; McPhaul MJ; Cheskis B; Mancini MA; Marcelli M
    Cancer Res; 2004 Oct; 64(19):7156-68. PubMed ID: 15466214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential expression of integrin subunits in DU-145/AR prostate cancer cells.
    Nagakawa O; Akashi T; Hayakawa Y; Junicho A; Koizumi K; Fujiuchi Y; Furuya Y; Matsuda T; Fuse H; Saiki I
    Oncol Rep; 2004 Oct; 12(4):837-41. PubMed ID: 15375509
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Androgen receptor auto-regulates its expression by a negative feedback loop through upregulation of IFI16 protein.
    Alimirah F; Chen J; Xin H; Choubey D
    FEBS Lett; 2006 Mar; 580(6):1659-64. PubMed ID: 16494870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5alpha-androstane-3alpha,17beta-diol supports human prostate cancer cell survival and proliferation through androgen receptor-independent signaling pathways: implication of androgen-independent prostate cancer progression.
    Yang Q; Titus MA; Fung KM; Lin HK
    J Cell Biochem; 2008 Aug; 104(5):1612-24. PubMed ID: 18320593
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of androgen receptor levels: implications for prostate cancer progression and therapy.
    Burnstein KL
    J Cell Biochem; 2005 Jul; 95(4):657-69. PubMed ID: 15861399
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of leupaxin with Src in osteoclasts.
    Sahu SN; Khadeer MA; Robertson BW; Núñez SM; Bai G; Gupta A
    Am J Physiol Cell Physiol; 2007 Jan; 292(1):C581-90. PubMed ID: 16914530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secreted frizzled-related protein 4 inhibits proliferation and metastatic potential in prostate cancer.
    Horvath LG; Lelliott JE; Kench JG; Lee CS; Williams ED; Saunders DN; Grygiel JJ; Sutherland RL; Henshall SM
    Prostate; 2007 Jul; 67(10):1081-90. PubMed ID: 17476687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.